This feature highlights changes in clinical trial organizations’ personnel.

Aridis Pharmaceuticals

Aridis Pharmaceuticals has hired Hasan Jafri to the role of chief medical officer. Jafri was most recently the senior medical director of clinical research and development at AstraZeneca.

BioXcel Therapeutics

William Kane, who previously served as a senior vice president at Allergan, has been appointed to the position of chief commercial officer at BioXcel Therapeutics.

CANbridge Pharmaceuticals

Carrie Ann Cook has been appointed to the role of senior vice president/global head of business development at CANbridge Pharmaceuticals. Most recently, Cook was senior director of the Center for External Innovation at Takeda Pharmaceuticals.

Catabasis Pharmaceuticals

Catabasis Pharmaceuticals has appointed Ben Harshbarger to the position of senior vice president and general counsel. Harshbarger was most recently interim CEO and general counsel at Novelion Therapeutics.

CURE Pharmaceutical

Jonathan Berlent has been named chief business officer of CURE Pharmaceutical. Berlent joined CURE from consultancy firm Wellness Life Science, where he served as managing partner.

Dyne Therapeutics

Dyne Therapeutics has hired Daniel Wilson to the position of vice president and head of intellectual property. Wilson was most recently senior corporate counsel at Celgene.

Edgewise Therapeutics

Kirsten Gruis, whose most recent position was global head of the neuromuscular franchise at Roche, will now serve as chief medical officer of Edgewise Therapeutics.

Erasca

Erasca has appointed Bao Truong to the role of vice president of regulatory affairs and David Luo to the position of vice president of clinical research and operations. Truong was head of regulatory affairs at IDEAYA Biosciences prior to joining Erasca; Luo previously served as vice president of clinical operations at Synthorx.

FerGene

Ambaw Bellete, former president of PhotoCure, has been named chief operating officer of FerGene. Vijay Kasturi was also appointed by FerGene to the role of vice president of medical affairs. Previously, Kasturi was head of U.S. medical affairs and oncology for EMD Serono. Additionally, FerGene has appointed Peter Olagunju, former vice president of global patient operations of bluebird bio, to the role of senior vice president of technical operations.

iTeos

Yvonne McGrath, former chief scientific officer at Complix, has been appointed to the role of vice president of R&D at iTeos.

Juvenescence

Ellen Donnelly has joined the anti-aging biotech Juvenescence as CEO of the company’s epigenetics division. Most recently, Donnelly was CEO of Modus Therapeutics.

Kronos Bio

Kronos Bio has tapped Christopher Dinsmore to serve as chief scientific officer. Dinsmore was most recently entrepreneur-in-residence at Third Rock Ventures.

MacroGenics

MacroGenics has appointed Stephen Eck to the role of chief medical officer. Eck was previously the chief medical officer of Immatics.

Metacrine

Preston Klassen will now lead Metacrine as its president and CEO. Previously, Klassen was executive vice president and head of research and development at Arena Pharmaceuticals.

Norgine B.V.

Christopher Bath, former chief financial officer of Norgine B.V., was appointed to the role of chief operating officer at the company.

Novavax

Novavax has named Filip Dubovsky the company’s chief medical officer. Dubovsky was formerly the chief medical officer and head of clinical engagement and policy at AstraZeneca.

RenovaCare

Jo Ellen Schweinle will now serve as chief medical officer at RenovaCare. Formerly, Schweinle was the senior medical officer at the U.S. Department of Health and Human Services.

Sirtex Medical

Mark Turco has been named global chief medical officer and executive vice president of research and development at Sirtex Medical. Prior to Sirtex, Turco served as chief innovation and corporate outreach officer for the University of Pennsylvania’s Penn Center for Innovation.

UK Vaccine Task Force

Clive Dix, the CEO of C4X Discovery, has been appointed by the UK government to deputy chair of the government’s vaccine task force, which is leading efforts to discover and manufacture a coronavirus vaccine.

Unicycive

Unicycive has named Keith Ward the company’s chief development officer. Ward was recently the executive vice president and chief development officer for Reata Pharmaceuticals.

 

Up and Coming

This feature highlights changes in clinical trial organizations’ personnel.

Aridis Pharmaceuticals

Aridis Pharmaceuticals has hired Hasan Jafri to the role of chief medical officer. Jafri was most recently the senior medical director of clinical research and development at AstraZeneca.

BioXcel Therapeutics

William Kane, who previously served as a senior vice president at Allergan, has been appointed to the position of chief commercial officer at BioXcel Therapeutics.

CANbridge Pharmaceuticals

Carrie Ann Cook has been appointed to the role of senior vice president/global head of business development at CANbridge Pharmaceuticals. Most recently, Cook was senior director of the Center for External Innovation at Takeda Pharmaceuticals.

Catabasis Pharmaceuticals

Catabasis Pharmaceuticals has appointed Ben Harshbarger to the position of senior vice president and general counsel. Harshbarger was most recently interim CEO and general counsel at Novelion Therapeutics.

CURE Pharmaceutical

Jonathan Berlent has been named chief business officer of CURE Pharmaceutical. Berlent joined CURE from consultancy firm Wellness Life Science, where he served as managing partner.

Dyne Therapeutics

Dyne Therapeutics has hired Daniel Wilson to the position of vice president and head of intellectual property. Wilson was most recently senior corporate counsel at Celgene.

Edgewise Therapeutics

Kirsten Gruis, whose most recent position was global head of the neuromuscular franchise at Roche, will now serve as chief medical officer of Edgewise Therapeutics.

Erasca

Erasca has appointed Bao Truong to the role of vice president of regulatory affairs and David Luo to the position of vice president of clinical research and operations. Truong was head of regulatory affairs at IDEAYA Biosciences prior to joining Erasca; Luo previously served as vice president of clinical operations at Synthorx.

FerGene

Ambaw Bellete, former president of PhotoCure, has been named chief operating officer of FerGene. Vijay Kasturi was also appointed by FerGene to the role of vice president of medical affairs. Previously, Kasturi was head of U.S. medical affairs and oncology for EMD Serono. Additionally, FerGene has appointed Peter Olagunju, former vice president of global patient operations of bluebird bio, to the role of senior vice president of technical operations.

iTeos

Yvonne McGrath, former chief scientific officer at Complix, has been appointed to the role of vice president of R&D at iTeos.

Juvenescence

Ellen Donnelly has joined the anti-aging biotech Juvenescence as CEO of the company’s epigenetics division. Most recently, Donnelly was CEO of Modus Therapeutics.

Kronos Bio

Kronos Bio has tapped Christopher Dinsmore to serve as chief scientific officer. Dinsmore was most recently entrepreneur-in-residence at Third Rock Ventures.

MacroGenics

MacroGenics has appointed Stephen Eck to the role of chief medical officer. Eck was previously the chief medical officer of Immatics.

Metacrine

Preston Klassen will now lead Metacrine as its president and CEO. Previously, Klassen was executive vice president and head of research and development at Arena Pharmaceuticals.

Norgine B.V.

Christopher Bath, former chief financial officer of Norgine B.V., was appointed to the role of chief operating officer at the company.

Novavax

Novavax has named Filip Dubovsky the company’s chief medical officer. Dubovsky was formerly the chief medical officer and head of clinical engagement and policy at AstraZeneca.

RenovaCare

Jo Ellen Schweinle will now serve as chief medical officer at RenovaCare. Formerly, Schweinle was the senior medical officer at the U.S. Department of Health and Human Services.

Sirtex Medical

Mark Turco has been named global chief medical officer and executive vice president of research and development at Sirtex Medical. Prior to Sirtex, Turco served as chief innovation and corporate outreach officer for the University of Pennsylvania’s Penn Center for Innovation.

UK Vaccine Task Force

Clive Dix, the CEO of C4X Discovery, has been appointed by the UK government to deputy chair of the government’s vaccine task force, which is leading efforts to discover and manufacture a coronavirus vaccine.

Unicycive

Unicycive has named Keith Ward the company’s chief development officer. Ward was recently the executive vice president and chief development officer for Reata Pharmaceuticals.